Clearview Capital Races to Equity and Mezzanine Fund Closes
Clearview Capital today announced the first and final closings of $550 million Clearview Capital Fund IV ("Fund IV" or the "Equity Fund") and $108 million Clearview Capital Mezzanine Fund I ("Mezzanine Fund I"), which were completed on June 29, 2018. Fund IV closed at its self-imposed hard cap and the Mezzanine Fund I was completed above its target...
Read More
Heard it Through the Grapevine...Clearview Backs Acquisitions of Two CA-Based Vineyard Suppliers by Wilson
Clearview Capital Fund III, LP (“Fund III”) announced today that its portfolio company, Wilson Orchard & Vineyard Supply, LLC (“Wilson”), has completed the acquisitions of Valley Vineyard and Quantum Irrigation. The transactions closed on February 2, 2018 and April 17, 2018, respectively...
Read More
Clearview Partners with Community Medical Services to Combat the Opioid Epidemic
Clearview Capital Fund III, LP (“Fund III”) announced today the acquisition, in partnership with management, of Community Medical Services Holdings, LLC (“CMS” or the “Company”). The transaction closed on March 30, 2018...
Read More
Clearview's Got Mail! With the Acquisition of Mudlick Mail
Clearview Capital Fund III, LP ("Fund III") announced today the acquisition, in partnership with management, of Mudlick Mail, LLC ("Mudlick" or the "Company"). The transaction closed on February 14, 2018...
Read More
Clearview Bids Adieu to the Big Easy by Exiting GCR, Inc.
January 8, 2018
Clearview Capital Fund II, LP (“Fund II”) today announced the sale of its majority interest in GCR, Inc. (“GCR”) to an affiliate of HKW Capital Partners. The transaction closed on December 21, 2017...
Read More
Case Closed: Clearview Exits Xact Data Discovery
January 3, 2018
Clearview Capital Fund III, LP ("Fund III") today announced the sale of its majority interest in Xcellence, Inc. dba Xact Data Discovery ("Xact") to an affiliate of JLL Partners. The transaction closed December 22, 2017...
Read More
The Conditions are Right as Clearview Acquires Nielsen-Kellerman Co.
Clearview Capital Fund III, LP (“Fund III”) announced today the acquisition, in partnership with management, of Nielsen-Kellerman Co. (“Nielsen-Kellerman” or the “Company”). The transaction closed on October 6, 2017....
Read More
Clearview Realizes First Fund III Exit with Sale of St. Croix
October 4, 2017
Almost four years to the day since its acquisition, Clearview Capital Fund III, LP ("Fund III") today announced the sale of its majority interest in St. Croix Hospice, LLC ("St. Croix") to an affiliate of The Vistria Group. The transaction closed on September 29, 2017...
Read More
Clearview’s Pyramid Healthcare Weaves Tapestry Eating Disorder Services into its Network
Third North Carolina Acquisition and Eighth Overall
July 10, 2017
Clearview Capital Fund II, L.P. (“Fund II”) today announced that its portfolio company, Pyramid Healthcare, Inc. (“Pyramid”), has completed the acquisition of Tapestry Eating Disorder Services of Western North Carolina (“Tapestry”). The transaction is Pyramid’s eighth add-on acquisition since Fund II recapitalized the company with its founder and CEO, Jonathan Wolf, in 2011. The transaction closed on June 30, 2017....Read More
Dreaming in Color: Clearview's Northwest Cosmetic Laboratories Acquires Dream Team Beaute
Clearview Capital Fund III, L.P. ("Fund III") announced today that its portfolio company, Northwest Cosmetic Laboratories, LLC ("NCL"), has completed the acquisition of Dream Team Beaute, LLC ("Dream Team") of Sun Valley, CA. The transaction closed on May 11, 2017...
Read More
